Cargando…
Tumour dormancy and clinical implications in breast cancer
The aim of adjuvant therapy in breast cancer is to reduce the risk of recurrence. Some patients develop metastases many years after apparently successful treatment of their primary cancer. Tumour dormancy may explain the long time between initial diagnosis and treatment of cancer, and occurrence of...
Autores principales: | Gelao, L, Criscitiello, C, Fumagalli, L, Locatelli, M, Manunta, S, Esposito, A, Minchella, I, Goldhirsch, A, Curigliano, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660156/ https://www.ncbi.nlm.nih.gov/pubmed/23717341 http://dx.doi.org/10.3332/ecancer.2013.320 |
Ejemplares similares
-
Best management of locally advanced inoperable breast cancer
por: Curigliano, Giuseppe, et al.
Publicado: (2013) -
Immune approaches to the treatment of breast cancer, around the corner?
por: Criscitiello, Carmen, et al.
Publicado: (2014) -
Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives
por: Criscitiello, Carmen, et al.
Publicado: (2014) -
Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”
por: Gelao, Lucia, et al.
Publicado: (2014) -
Impact of autoimmune diseases on outcome of patients with early breast cancer
por: Criscitiello, Carmen, et al.
Publicado: (2016)